Annexon Biosciences
Jennifer Lew has an extensive background in finance and leadership roles, with experience at companies such as Boundless Bio, Annexon Biosciences, Aduro Biotech, Inc., Dynavax Technologies, and QRS Corporation. Jennifer also has a strong educational background, having earned a BA in Economics/Accounting and Government from Claremont McKenna College. Additionally, Jennifer held the position of Audit Manager at Ernst & Young.
This person is not in any offices
Annexon Biosciences
2 followers
Annexon is a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.